Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519766 · ClinicalTrials.gov registry record
Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT
A clinical trial, sponsored by Memorial Hospital of Rhode Island.
- Completed
- Registry status
- 252
- Enrollment target
NCT00519766: Completed study, sponsored by Memorial Hospital of Rhode Island.
NCT00519766 is a clinical trial that has completed, run by Memorial Hospital of Rhode Island. The registered enrollment target is 252 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519766 has completed, sponsored by Memorial Hospital of Rhode Island.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
Study Summary
Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant women are less likely to disclose their smoking status to doctors or study researchers. This study will evaluate the use of a new biomarker of nicotine metabolism to estimate tobacco use in a group of pregnant women who participated in the New England Smoking Cessation and Reduction in Pregnancy Trial (SCRIPT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 1997-09 |
| Est. Completion | 2002-11 |
What the finished NCT00519766 record still lists
NCT00519766 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00519766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00519766 about?
NCT00519766 is a clinical study titled "Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT". Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant women are less likely to disclose their smoking status to doctors or study researchers. This study will evaluate ...
What is the current status of trial NCT00519766?
This trial is currently completed. The enrollment target is 252 participants. The study started on 1997-09. Estimated completion is 2002-11.
Who is sponsoring clinical trial NCT00519766?
This trial is sponsored by Memorial Hospital of Rhode Island, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia